- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
Penumbra is a medical devices business based in the US. Penumbra shares (PEN) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $242.54 – a decrease of 1.23% over the previous week. Penumbra employs 4,200 staff and has a trailing 12-month revenue of around $1.2 billion.
What's in this guide?
Our top picks for where to buy Penumbra stock
- Trade $0 commission stocks & ETFs with as little as $1
- Earn up to $300 with qualifying deposits
- Discover new opportunities with Opto's AI-driven thematic investing system
- Theme and ETF screener
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options with no options contract fees
- Get up to $1,000 in stock when you fund a new account within 30 days
- Complimentary access to a financial planner
How to buy Penumbra stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – PEN. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Penumbra stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.What is the Finder Score?
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Penumbra stock price (NYSE: PEN)
Use our graph to track the performance of PEN stocks over time.Penumbra shares at a glance
Latest market close | $242.54 |
---|---|
52-week range | $148.00 - $277.34 |
50-day moving average | $228.50 |
200-day moving average | $206.41 |
Wall St. target price | $257.60 |
PE ratio | 277.7907 |
Dividend yield | N/A |
Earnings per share (TTM) | $0.86 |
Is it a good time to buy Penumbra stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Penumbra price performance over time
Historical closes compared with the close of $242.54 from 2024-12-20
1 week (2024-12-13) | -1.23% |
---|---|
1 month (2024-11-22) | -0.94% |
3 months (2024-09-20) | 24.38% |
6 months (2024-06-21) | 35.83% |
1 year (2023-12-22) | -6.20% |
---|---|
2 years (2022-12-22) | 8.50% |
3 years (2021-12-22) | 271.08 |
5 years (2019-12-20) | 51.89% |
Is Penumbra stock undervalued or overvalued?
Valuing Penumbra stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Penumbra's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Penumbra's P/E ratio
Penumbra's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 278x. In other words, Penumbra shares trade at around 278x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Penumbra's EBITDA
Penumbra's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $102.5 million.
The EBITDA is a measure of a Penumbra's overall financial performance and is widely used to measure a its profitability.
Penumbra financials
Revenue TTM | $1.2 billion |
---|---|
Operating margin TTM | 11.75% |
Gross profit TTM | $535.2 million |
Return on assets TTM | 3.33% |
Return on equity TTM | 3.13% |
Profit margin | 2.97% |
Book value | $28.79 |
Market Capitalization | $9.2 billion |
TTM: trailing 12 months
Penumbra share dividends
We're not expecting Penumbra to pay a dividend over the next 12 months.
Have Penumbra's shares ever split?
Penumbra's shares were split on a 10:1 basis on 15 November 2014 . So if you had owned 1 share the day before before the split, the next day you'd have owned 10 shares. This wouldn't directly have changed the overall worth of your Penumbra shares – just the quantity. However, indirectly, the new 90% lower share price could have impacted the market appetite for Penumbra shares which in turn could have impacted Penumbra's share price.
Penumbra share price volatility
Over the last 12 months, Penumbra's shares have ranged in value from as little as $148 up to $277.34. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Penumbra's is 0.514. This would suggest that Penumbra's shares are less volatile than average (for this exchange).
Penumbra overview
Penumbra, Inc. , together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors.
Frequently asked questions
What percentage of Penumbra is owned by insiders or institutions?Currently 3.874% of Penumbra shares are held by insiders and 93.516% by institutions. How many people work for Penumbra?
Latest data suggests 4,200 work at Penumbra. When does the fiscal year end for Penumbra?
Penumbra's fiscal year ends in December. Where is Penumbra based?
Penumbra's address is: One Penumbra Place, Alameda, CA, United States, 94502 What is Penumbra's ISIN number?
Penumbra's international securities identification number is: US70975L1070 What is Penumbra's CUSIP number?
Penumbra's Committee on Uniform Securities Identification Procedures number is: 70975L107
More guides on Finder
-
Best Stocks for Beginners With Little Money to Invest
These are the stocks to buy when you don’t have much to spend.
-
Sweep Accounts
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
7 Best Day Trading Apps of 2024
These are the best day trading apps, according to Finder’s comprehensive analysis.
-
Today’s Best Brokerage Account Bonuses [Signup and Transfer Promos]
Explore the best bonuses for opening a new brokerage account.
-
5 best stock picking services of 2024
Compare the 5 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
-
5 Top Graphene Stocks to Invest in Today
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
-
Ratings methodology for online brokers
Our star ratings for online brokerages are based on how they stack up in nine key categories.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to Invest $10K
Maximize $10,000 with broker bonuses, IRA contribution matches, index funds, stocks, ladder CDs, hiring a financial advisor and more.
-
5 best ETFs for 2024
Check out the best-performing ETFs so far in 2024.
Ask a question